CommunityConnect with experts, uncover more opportunities
1.85K
Selection
WallStreet_Tiger
·
08-20

🪙 The Great Wall Street Divide: 2 Upgrades, 2 Downgrades — Who's Right About AI's Next Move?

$Alphabet(GOOG)$ and $PayPal(PYPL)$ just got the bull case reloaded. $CrowdStrike Holdings, Inc.(CRWD)$ and $Palantir Technologies Inc.(PLTR)$ just got downgraded. Four calls, two very different views of where money is heading next. On one side: Alphabet, where massive AI spending is finally translating into stronger Cloud growth and a $514B backlog. On the other: CrowdStrike and Palantir, two AI winners still delivering strong growth but trading at valuations that leave much less room for disappointment. PayPal sits somewhere else entirely — its near-term t
🪙 The Great Wall Street Divide: 2 Upgrades, 2 Downgrades — Who's Right About AI's Next Move?
TOP苏36: Alphabet Still Wins Among these four calls, I agree most with the Alphabet upgrade. The key is that Google's AI investment is no longer just a massive spending story. Google Cloud is accelerating, margins are improving, the backlog is huge, and its in-house TPU technology could eventually strengthen both competitiveness and profitability. That gives GOOG a compelling AI re-rating opportunity. I'm more cautious on CRWD and PLTR. Both remain excellent businesses with strong growth, but their valuations already assume years of near-perfect execution. At such multiples, even a small slowdown can trigger a sharp correction. PYPL is the wildcard. The potential M&A deal could create upside, but it is fundamentally an event-driven trade rather than a pure turnaround story. My ranking: GOOG first, PYPL second for aggressive investors, CRWD and PLTR on pullbacks. The lesson is simple: in 2026, AI exposure alone isn't enough — valuation and cash-flow visibility matter. @WallStreet_Tiger [真香]
6
Report
1.34K
Selection
Tiger_Earnings
·
08-20

[Earnings Recap] Estée Lauder Soars 16%, Target Gains 4% — Is the Consumer Rebound?

Consumer earnings were in focus Wednesday, and the market reactions were surprisingly strong. Estée Lauder surged 16% as China and fragrance demand improved, while Target gained 4% after raising its full-year outlook. Lowe’s also moved higher despite softer sales, while TJX fell even after beating expectations. $Estee Lauder(EL)$ +16.3% Estée Lauder is a global beauty company behind brands including Estée Lauder, Clinique, M.A.C, Tom Ford Beauty and Le Labo. Estée Lauder delivered a strong finish to fiscal 2026, with Q4 sales of $3.63 billion, ahead of the $3.54 billion Wall Street expected. Adjusted EPS came in at $0.39, beating the $0.32 consensus. Luxury fragrance remained the standout. Fragrance sales rose 10%, helped by Tom Ford and Le Labo, wh
[Earnings Recap] Estée Lauder Soars 16%, Target Gains 4% — Is the Consumer Rebound?
TOPShyon: If I had to choose between Target and Estée Lauder after earnings, I’d lean toward $Estee Lauder(EL)$ . The 16% jump is significant, but the results suggest its turnaround may finally be gaining traction. Improving China demand and strong fragrance growth from Tom Ford and Le Labo give me more confidence in its recovery. I also like $Target(TGT)$ setup, with stronger traffic, digital sales growth and a raised full-year outlook. However, part of the EPS strength came from tariff refunds, so I’d like to see more evidence that earnings can continue improving without one-off benefits. For me, EL has more upside potential, while TGT is the steadier recovery play. I’d choose EL, but wouldn’t chase the 16% move—I’d rather wait for a pullback and see if the fundamentals continue improving. @TigerStars @TigerClub @Tiger_comments @Tiger_Earnings
2
Report
1.11K
General
闲置多巴胺
·
08-19

NVDA Earnings Review: Fundamental Highlight, But Market Focuses on AI Demand Durability

NVIDIA enters this earnings report with market expectations already set at an unusually high level. Consensus for the current quarter points to revenue of $91.89 billion for the quarter, up 99.50% year over year, EBIT of $60.72 billion, up 110.03% year over year, and EPS of $2.089, up 107.20% year over year. Those forecasts matter not just because they imply another near-doubling in scale, but because they come after a prior quarter in which revenue already reached $81.62 billion, up 85.23% year over year, and profitability stayed exceptionally strong. In practical terms, investors are no longer asking whether NVIDIA is growing fast; the core variable for the stock reaction is whether AI infrastructure demand can keep supporting this pace while preserving margins at levels that remain far
NVDA Earnings Review: Fundamental Highlight, But Market Focuses on AI Demand Durability
TOPfloopi: 71.46% net margin is absurd, but AI demand durability is still the whole debate. If gross margin slips even a bit, this market won't treat a simple beat kindly
1
Report
672
General
zhingle
·
08-19
NVIDIA Drops 2.3% Before Earnings — I’m Still Bullish 🚀 NVIDIA just gave investors a better entry point. Shares fell 2.3% Tuesday, as the entire semiconductor complex sold off, with NVDA now sitting around the $225 area ahead of its Aug. 26 earnings. The market is suddenly questioning whether AI spending has gone too far, whether NVIDIA is financing its own demand, and whether challengers like Cerebras and Groq can finally take share. My take? The market is focusing on the wrong risk. I’m bullish into earnings. 1. The fundamental numbers are still extremely hard to ignore NVIDIA’s last quarter was not a company showing signs of slowing down. Q1 FY27 revenue hit $81.6B, +85% YoY, while Data Center revenue reached $75.2B, +92% YoY. Even more important: NVIDIA guided Q2 revenue to approximate
NVIDIA Drops 2.3% Before Earnings — I’m Still Bullish 🚀 NVIDIA just gave investors a better entry point. Shares fell 2.3% Tuesday, as the entire se...
TOPtwiddly: Capex slowing is the part I can't wave off. If hyperscalers tap the brakes, that bottleneck can turn into inventory pain fast lol
1
Report
602
Selection
Tiger_SG
·
08-20
Markets are being reshaped by oil price swings, inflation, geopolitical tensions and AI-driven earnings. Join us on 21 August for “Q3 Markets Commentary” with Jonathan Lo to unpack the key trends shaping the months ahead.

[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo

@TigerEvents
Oil price volatility continues to shape the interest rate outlook, reinforcing the Fed's higher-for-longer stance amid persistent inflation. Meanwhile, rising geopolitical risks are driving market volatility, even as the expanding AI cycle supports resilient global earnings. Against this backdrop, exposure to different geographical markets may offer varied perspectives on regional economic and market conditions. Join Jonathan Lo, Investment Representative at Tiger Brokers (Singapore), as he explores the macro landscape dominating our mindspace in Q3. 📅 Event Time: 21 August 2026, 7pm - 9pm 📍 Venue: Tiger Brokers Office 🎤 Guest Speaker: Name: Jonathan Lo (RNF: LNH300307561) Title: Investment Representative Company: Tiger Brokers (S
[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo
Markets are being reshaped by oil price swings, inflation, geopolitical tensions and AI-driven earnings. Join us on 21 August for “Q3 Markets Comme...
Comment
Report
554
Selection
Tiger_SG
·
08-20
Looking to invest with greater discipline and conviction? Join us on 27 August for “A Practical Guide to Value Investing in 2026” with Jeremy Tan and explore practical strategies for navigating today’s market.

[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer

@TigerEvents
Ever wondered how the classic value investing concepts — including margin of safety, Mr. Market and high-ROIC businesses, have evolved through the work of Buffett, Munger, Li Lu and others? Join Jeremy Tan, Investment Representative at Tiger Brokers (Singapore), as he shares how these concepts relate to modern market mechanics, including position sizing, catalysts and options. He will also bring you through the Barbell portfolio approach in global and Singaporean markets, alongside analytical frameworks used to assess global equities and the broader SEA small-cap market. 📅 Event Time: 27 August 2026, 7pm - 9pm 📍 Venue: Tiger Brokers Office 🎤 Guest Speaker: Name: Jeremy Tan (RNF No.: TTJ100095010) Title: Investment Representative Compan
[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer
Looking to invest with greater discipline and conviction? Join us on 27 August for “A Practical Guide to Value Investing in 2026” with Jeremy Tan a...
Comment
Report
3.07K
General
Hui Fen88
·
08-19

[MINDSET SHIFT] Why You Can Be Wrong 60% of the Time and Still Make Money

Most new traders treat trading like a school exam—they think if they aren't right 80% or 90% of the time, they are failing. This belief causes beginners to hold losing trades forever just to avoid taking a loss and ruining their "win rate." Here is the secret: Win rate doesn't determine profitability—Risk-to-Reward Ratio (R:R) does. What Is Risk-to-Reward Ratio? Your Risk-to-Reward Ratio measures how much money you stand to lose versus how much money you stand to gain on a single trade. 1:1 R:R: You risk $10 to make $10. 1:2 R:R: You risk $10 to make $20. 1:3 R:R: You risk $10 to make $30. The 10-Trade Math Experiment Assume you take 10 trades risking $20 per trade with a 1:3 Risk-to-Reward Ratio. You have a terrible week and lose 6 out of 10 trades (a 40% win rate). Even though you were w
[MINDSET SHIFT] Why You Can Be Wrong 60% of the Time and Still Make Money
TOPMaudNelly: Backtested VOO over the past 5 years, 1:3 with roughly 40% hit rate looked best on paper, but 1:2 was way easier to execute without strategy drift
2
Report
809
General
DengDeng
·
08-20
$Strategy(MSTR)$  still bullish but sold to buy back if I could if there is some retracement, if not move on to other trades
$Strategy(MSTR)$ still bullish but sold to buy back if I could if there is some retracement, if not move on to other trades
Comment
Report
333
General
DengDeng
·
08-20
$IBM(IBM)$  sold another half ibm in this account left with some long call in ibm
$IBM(IBM)$ sold another half ibm in this account left with some long call in ibm
Comment
Report
3.54K
General
AMDidass
·
08-20
$Advanced Micro Devices(AMD)$  it's coming down to give us chance again! Just click buy and buy then wait for profit! See my name then you will know I'm AMD lover! $Tesla Motors(TSLA)$  another share that I'm monitoring! It's going fly more later once market open! Let's see!
$Advanced Micro Devices(AMD)$ it's coming down to give us chance again! Just click buy and buy then wait for profit! See my name then you will know...
TOPCecilFranklin: For Tesla, I care more about the 4680 ramp than the opening pop. That is what really sets the ceiling for next year's deliveries.
3
Report
1.66K
Selection
TigerEvents
·
08-19

[Wednesday This or That] A Stock Down 30% or One at an All-Time High?

Every Wednesday, we’re putting two investing choices Here’s today’s matchup: A | A company you like, but the stock is down 30% from its high B | A strong stock that has just hit a new all-time high If you had to buy one today, are you picking A or B? 👇[Thinking][Thinking] $NVIDIA(NVDA)$ $Tesla Motors(TSLA)$ $OCBC Bank(O39.SI)$ $SpaceX(SPCX)$ $Micron Technology(MU)$ $SanDisk Corp.(SNDK)$ $SK hynix(SKHY)$ Drop your pick and tell us why for a chance to win some Tiger Coins [Allin][Allin] Rewards a
[Wednesday This or That] A Stock Down 30% or One at an All-Time High?
TOPkoolgal: 🌟🌟🌟The Ultimate Trader's Dilemma: The 30% Discount Bunker vs The All Time High Starship. Team A: The Discount Bunker. If your inner contrarian loves a bargain, choose A. $SpaceX(SPCX)$ falls into Team A. After a breathless IPO launch to an intraday peak of USD 225, Elon Musk's Starship has crashed back to Earth with a 30% discount. $Micron Technology(MU)$ the premier US memory giant is down 28% as short term traders panicked over infrastructure pacing. $Tesla Motors(TSLA)$ has plunged 26% lower as Wall Street temporarily forgot its autonomous robotics long game. Choose Team B if you believe that strength begets strength & you refuse to catch falling knives. Choose $NVIDIA(NVDA)$ the King of AI revolution if you trust that its multi billion data center monopoly will continue to prevail. Choose $OCBC Bank(O39.SI)$ for a touch of financial safety as it has recently reached its all time high. I choose A as it has a built in margin of safety. My top pick is Micron.
15
Report
613
Selection
TigerEvents
·
08-20

[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo

  Oil price volatility continues to shape the interest rate outlook, reinforcing the Fed's higher-for-longer stance amid persistent inflation. Meanwhile, rising geopolitical risks are driving market volatility, even as the expanding AI cycle supports resilient global earnings. Against this backdrop, exposure to different geographical markets may offer varied perspectives on regional economic and market conditions.   Join Jonathan Lo, Investment Representative at Tiger Brokers (Singapore), as he explores the macro landscape dominating our mindspace in Q3.   📅 Event Time: 21 August 2026, 7pm - 9pm   📍 Venue: Tiger Brokers Office   🎤 Guest Speaker: Name: Jonathan Lo (RNF: LNH300307561) Title: Investment Representative Company: Tiger Brokers (S
[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo
TOPTiger_SG: Markets are being reshaped by oil price swings, inflation, geopolitical tensions and AI-driven earnings. Join us on 21 August for “Q3 Markets Commentary” with Jonathan Lo to unpack the key trends shaping the months ahead.
1
Report
517
Selection
TigerEvents
·
08-20

[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer

  Ever wondered how the classic value investing concepts — including margin of safety, Mr. Market and high-ROIC businesses, have evolved through the work of Buffett, Munger, Li Lu and others?   Join Jeremy Tan, Investment Representative at Tiger Brokers (Singapore), as he shares how these concepts relate to modern market mechanics, including position sizing, catalysts and options. He will also bring you through the Barbell portfolio approach in global and Singaporean markets, alongside analytical frameworks used to assess global equities and the broader SEA small-cap market.   📅 Event Time: 27 August 2026, 7pm - 9pm   📍 Venue: Tiger Brokers Office   🎤 Guest Speaker: Name: Jeremy Tan (RNF No.: TTJ100095010) Title: Investment Representative Compan
[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer
TOPTiger_SG: Looking to invest with greater discipline and conviction? Join us on 27 August for “A Practical Guide to Value Investing in 2026” with Jeremy Tan and explore practical strategies for navigating today’s market.
1
Report
633
General
SmartReversals
·
08-20

Gold & Silver Take Center Stage as SPX Tests 7,730

$Gold - main 2612(GCmain)$ doesn’t behave like a stock or a bond. There are no earnings to model, no dividends to discount, and no CEO to blame when the price drops. What gold reflects, more than anything else, is the collective confidence people have in the institutions managing money. When that confidence is high, gold is ignored. When it starts to crack, gold gets attention fast. $Silver - main 2609(SImain)$ follows the same logic but adds a wrinkle: it has a real industrial life. Solar panels, electronics, electric vehicles, medical equipment. That dual identity makes silver louder, more volatile, and more interesting to trade, but also harder to hold when the industrial cycle turns against it
Gold & Silver Take Center Stage as SPX Tests 7,730
Comment
Report
1.48K
General
PeterDiCarlo
·
08-20

My Key Levels Across NBIS, CIFR, SPCX & More

NBIS, CIFR, SPCX, SG, NVDA & TEM: Key Levels to Watch Hey Tiger Brokers friends! 👋 Here’s a quick update on several names I’m watching closely today. The focus is on key support levels, potential pullbacks, and where I’d look for the next opportunity. 1. $NEBIUS(NBIS)$ : $220 Is the Key Level $NBIS is now down around 20% from our previous take-profit/short call. We’ve reached an EXTREMELY important level here. I expect price to hold in the short term, but if the $220 volume block breaks, I would expect the move to extend lower toward $140. For now, the key is whether $220 can hold. 2. $Cipher Mining Inc.(CIFR)$ : The Pullback Finally Arrived Last month, I called out the possibility of a move down into
My Key Levels Across NBIS, CIFR, SPCX & More
1
Report
768
General
Travis Hoium
·
08-20

Uber, Zeta, Hims & Nebius: 4 Stocks With Something to Prove

4 Stocks Where Fundamentals Are Telling a Different Story 📊 1. $Uber(UBER)$ — Bookings Still Matter Most For Uber, gross bookings remain one of the most important metrics to watch. So far, there's little evidence that Waymo is disrupting Uber's core business. The key question isn't whether autonomous driving will change mobility — it will. The question is whether Uber's marketplace can continue growing before that disruption becomes meaningful. For now, the bookings data is still telling a relatively strong story. 🚗 2. $Zeta Global Holdings Corp.(ZETA)$ — Growth Isn't the Question Zeta is clearly out-growing many of its competitors. That's not really the debate anymore. The bigger question is: How much
Uber, Zeta, Hims & Nebius: 4 Stocks With Something to Prove
Comment
Report
1.25K
Selection
nerdbull1669
·
08-20

Treasury Liquidity Injections, Yield Curve Dynamics, and Digital Asset Legislation: Strategic Implications for Markets and Stocks

In this article, we would like to share an in-depth analysis of recent macroeconomic and regulatory developments impacting global fixed income, corporate debt markets, and the digital asset ecosystem. Following a sharp spike in long-end sovereign yields driven by war risks and national debt approaching $40 trillion, the U.S. Treasury announced a doubling of its liquidity-support buybacks for 10-to-30-year Treasuries to at least $4 billion per operation through November 4, 2026. $US Treasury 10 Year Note ETF(UTEN)$ This intervention successfully suppressed 30-year yields to ~5.19% and injected vital liquidity into the long end. Simultaneously, digital asset markets have surged as institutional investors migrate toward hard assets and regulatory mom
Treasury Liquidity Injections, Yield Curve Dynamics, and Digital Asset Legislation: Strategic Implications for Markets and Stocks
TOPOutsiderLEO: The buyback angle helps liquidity, but credit spreads can still widen and eat the financing benefit. For MSTR especially, lower Treasury yields do not automatically mean meaningfully cheaper capital.
4
Report
645
General
Michael Esther
·
08-20

4 SPY Stocks Down 40%-60%, But EPS Keeps Rising

These 4 stocks are down 40%-60% from its highs. But, EPS keeps going up every quarter for each of them too. Here's the 4 most undervalued stocks in $SPDR S&P 500 ETF Trust(SPY)$ : 1st stock is: $Fair Isaac(FICO)$ its down almost 40% right now. It has never printed a loss quarter and eps keeps accelerating. Honestly, it shouldn't even be down this year. It actually makes no sense to me. $FICO -Fiscal Q3 revenue $674M, up 26%. -GAAP EPS $10.45, up 41%. Non GAAP $12.18, up 42%. -$370M of free cash flow in a single quarter. -Platform ARR up 62% to $413M, now bigger than legacy for the first time. -Repurchased $1.96B of stock in the quarter. Yes, its very expensive this stock. So here's 3 more that are chea
4 SPY Stocks Down 40%-60%, But EPS Keeps Rising
Comment
Report
2.63K
General
Michael Esther
·
08-20

Cancer Vaccine Phase 3: 5 Biotechs On the Brink

$Moderna, Inc.(MRNA)$ just showed how explosive a successful cancer-vaccine catalyst can be. A $1,000 overnight options bet reportedly turned into more than $7.3M after Moderna announced a major Phase 3 win for its personalized cancer vaccine program. But here's the catch: This is an extremely high-risk game. Two cancer-vaccine Phase 3 programs have already failed in 2026, including $IOBT, which filed for Chapter 7 after missing its primary endpoint, and $IMMP, which discontinued its Phase 3 program for futility. So the next wave of catalysts could create massive winners — or wipe out years of work. Here are 5 biotech names with major clinical readouts ahead: 1. $CG Oncology Inc.(CGON)$ Oncolytic virus de
Cancer Vaccine Phase 3: 5 Biotechs On the Brink
TOPZtradee: Thanks for such interesting write up (and literally your handwritten notes!). Your reminder of such stocks' risk will be useful for inexperience investors out there. Then again, very rarely, if successful, one could real in handsome profits. Caveat emptor!
1
Report
1.26K
General
jfsrevg
·
08-20

Only 12 of 34 Leaders Still Hold All Major MAs

Only 12 of the 34 strongest movers with a market cap above $10B are still trading above all their major moving averages. That tells us something important: Headline strength is still concentrated. A handful of stocks continue to show strong relative strength since August 6, but the broader setup remains selective rather than broadly bullish. 🔥 The strongest RS names include: $SpaceX(SPCX)$ — Aerospace & Defense One of the strongest relative-strength names since Aug. 6. $TPG, Inc.(TPG)$ — Asset Management $Dell Technologies Inc.(DELL)$ — Computer Hardware $SUPER MICRO COMPUTER INC(SMCI)$ — Computer Hardware
Only 12 of 34 Leaders Still Hold All Major MAs
Comment
Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24